SCHEMBL23917713

SCHEMBL23917713

Clc1cc(N2CCCc3ccccc32)cc(N2CCCc3ccccc32)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPR P35270 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ROCK1 Q13464 1/20 0.46
NOTUM Q6P988 1/20 0.45
AVPR2 P30518 1/20 0.44
AVPR1A P37288 1/20 0.44
TP53 P04637 1/20 0.44
NUDT1 P36639 1/20 0.44
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
EED O75530 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917430 0.91 MAPT (0.43) SPRSMN1; SMN2L3MBTL1MAPTKDM4E
SCHEMBL23917696 0.85 ALDH1A1 (0.41) SPRSMN1; SMN2L3MBTL1MAPTKDM4E
SCHEMBL8332463 0.81 SLC6A2 (0.56) AVPR2EED
SCHEMBL29478502 0.80 ROCK1 (0.51) SMN1; SMN2L3MBTL1MAPTUSP2ALDH1A1
SCHEMBL693233 0.80 ROCK1 (0.51) SMN1; SMN2L3MBTL1MAPTUSP2ALDH1A1
SCHEMBL7621219 0.80 AVPR2 (0.55) MAPTTSHRAVPR2AVPR1ATP53
SCHEMBL22975005 0.78 NUDT1 (0.43) SMN1; SMN2L3MBTL1MAPTALDH1A1MAPK1
SCHEMBL17374725 0.77 OPRM1 (0.47) SMN1; SMN2L3MBTL1ALDH1A1TSHRROCK1
SCHEMBL10623473 0.76 KDM4E (0.50) SMN1; SMN2L3MBTL1MAPTKDM4EUSP2
SCHEMBL23908719 0.76 ROCK1 (0.43) SMN1; SMN2L3MBTL1MAPTMAPK1ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320254-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320254-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME ORAI2, SLC39A11, SLC39A7 SPR 4782/4885SMN1; SMN2 4340/4885L3MBTL1 853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.